Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 175

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Controlled‐release oxycodone compared with controlled‐release morphine in the treatment of cancer pain: A randomized, double‐blind, parallel‐group study

Mucci‐LoRusso, Patricia, Berman, Barry S., Silberstein, Peter T., Citron, Marc L., Bressler, Linda, Weinstein, Sharon M., Kaiko, Robert F., Buckley, Barbara J., Reder, Robert F. · 1998 · European Journal of Pain

Abstract

Controlled‐release oral formulations of oxycodone and morphine are both suitable analgesics for moderate to severe pain. They were compared in cancer‐pain patients randomized to double‐blind treatment with controlled‐release oxycodone (n = 48) or controlled‐release morphine (n = 52) every 12 h for up to 12 days. Stable analgesia was achieved by 83% of controlled‐release oxycodone and 81% of controlled‐release morphine patients in 2 days (median). Following titration to stable analgesia, pain intensity (0/none to 3/severe) decreased from baseline within each group (p≤ 0.005), from 1.9 (0.1) to 1.3 (0.1), mean (SE), with controlled‐release oxycodone, and from 1.6 (0.1) to 1.0 (0.1) with controlled‐release morphine (no significant between‐group differences). Typical opioid adverse experiences were reported in both groups. Hallucinations were reported only with controlled‐release morphine (n = 2). Visual analog scores (VAS) for ‘itchy’ and ‘scratching’ were lower with controlled‐release oxycodone (p≤ 0.044), as was peak‐to‐trough fluctuation in steady‐state plasma concentration (p = 0.004). The correlation between plasma concentration and dose was stronger (p = 0.026) for oxycodone (0.7) than morphine (0.3). The relationship between pain intensity (VAS) and plasma concentration was more positive for oxycodone (p = 0.046). There was a positive relationship between morphine‐6‐glucuronide concentrations and urea nitrogen and creatinine levels (p = 0.0001). Controlled‐release oxycodone was as effective as controlled‐release morphine in relieving chronic cancer‐related pain, and as easily titrated to the individual's need for pain control. While adverse experiences were similar, controlled‐release oxycodone was associated with less itching and no hallucinations. Controlled‐release oxycodone provides a rational alternative to controlled‐release morphine for the management of moderate to severe cancer‐related pain.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s1090-3801(98)90020-9

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 175

Metadata

Authors
Mucci‐LoRusso, P., Berman, B. S., Silberstein, P. T., Citron, M. L., Bressler, L., Weinstein, S. M., Kaiko, R. F., Buckley, B. J., & Reder, R. F.
Venue
European Journal of Pain
Publisher
Wiley
Published
1998-09
Volume
2
Issue
3
Pages
239-249
ISSN
  • 1090-3801 (ISSN-L)
  • 1532-2149
OpenAlex
W2071858540
Cited by
175
References
2
FWCI
3.94
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Controlled‐release oxycodone compared with controlled‐release morphine in the treatment of cancer pain: A randomized, double‐blind, parallel‐group study. https://app.cochat.ai/papers/10.1016/s1090-3801(98)90020-9
The paper
Mucci‐LoRusso, P., Berman, B. S., Silberstein, P. T., Citron, M. L., Bressler, L., Weinstein, S. M., Kaiko, R. F., Buckley, B. J., & Reder, R. F. (1998). Controlled‐release oxycodone compared with controlled‐release morphine in the treatment of cancer pain: A randomized, double‐blind, parallel‐group study. European Journal of Pain. https://doi.org/10.1016/s1090-3801(98)90020-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.